The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 7,467 | 69,000 | SH | SOLE | 69,000 | 0 | 0 | ||
| ACCURAY INC | COM | 004397105 | 9,776 | 1,975,000 | SH | SOLE | 1,975,000 | 0 | 0 | ||
| AMERISOURCEBERGEN CORP | COM | 03073E105 | 6,494 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL IN | COM | 09060J106 | 7,820 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 6,313 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| CARDINAL HEALTH INC | COM | 14149Y108 | 6,318 | 104,000 | SH | SOLE | 104,000 | 0 | 0 | ||
| CIGNA CORP NEW | COM | 125523100 | 6,285 | 26,000 | SH | SOLE | 26,000 | 0 | 0 | ||
| COHERUS BIOSCIENCES INC | COM | 19249H103 | 9,643 | 660,000 | SH | SOLE | 660,000 | 0 | 0 | ||
| CVS HEALTH CORP | COM | 126650100 | 6,395 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 16,211 | 1,450,000 | SH | SOLE | 1,450,000 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 6,436 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 13,980 | 534,000 | SH | SOLE | 534,000 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 7,694 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
| UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 7,203 | 54,000 | SH | SOLE | 54,000 | 0 | 0 | ||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 7,521 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||